ContextVision AB (publ) (OSL:CONTX)

Market Cap	387.45M +11.0%
Revenue (ttm)	121.88M +0.1%
Net Income	13.48M +40.6%
EPS	0.18 +43.0%
Shares Out	74.51M
PE Ratio	29.07
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,713
Open	5.42
Previous Close	5.20
Day's Range	5.26 - 5.42
52-Week Range	2.70 - 5.78
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2026

About ContextVision AB

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardio...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1989
• Employees: 39
• Stock Exchange: Oslo Børs
• Ticker Symbol: CONTX

Financial Performance

In 2025, ContextVision AB's revenue was 110.28 million, a decrease of -15.61% compared to the previous year's 130.67 million. Earnings were 787,000, a decrease of -96.81%.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 5, 2026

Data Sources Report a data error